List of insiders holdings for IDEAYA Biosciences Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| CANAAN X L.P. Canaan Partners X LLC 10% Owner | 2024-02-01 16:33:27 | 1,570,820 0 | 1,570,820 | Form 13G |
| BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N See Explanation of Responses | 2024-11-14 16:23:02 | 1,409,993 0 | 1,409,993 | Form 13G |
| 5AM Ventures IV L.P. 5AM Co-Investors IV L.P. 5AM Partners IV LLC 5AM Opportunities I L.P. 5AM Opportunities I (GP) LLC DIEKMAN JOHN D Schwab Andrew J. ROCKLAGE SCOTT M Former 10% holder 10% Owner | 2021-08-11 16:31:32 | 1,398,066 0 | 1,398,066 | Form 13D |
| Hata Yujiro S President and CEO | 2024-05-16 17:51:24 | 978,971 0 | 978,971 | Form 4 |
| Alexandria Venture Investments LLC 10% Owner | 2019-05-30 18:12:17 | 432,384 0 | 432,384 | Form 4 |
| DORMAN STUART Chief Commercial Officer | 2024-12-20 16:53:22 | 170,000 0 | 170,000 | Form 3 |
| Beaupre Darrin Chief Medical Officer | 2024-03-04 17:27:00 | 160,000 0 | 160,000 | Form 4 |
| Snyder Douglas B. SVP, General Counsel | 2024-09-27 16:25:26 | 140,000 0 | 140,000 | Form 4 |
| Hager Jeffrey SVP, Chief Technology Officer | 2019-07-30 19:20:15 | 138,249 0 | 138,249 | Form 4 |
| Throne Jason Chief Legal Officer | 2024-06-27 18:47:10 | 106,030 0 | 106,030 | Form 4 |
| Dillon Michael P. SVP, Chief Scientific Officer | 2021-10-07 16:11:25 | 102,226 0 | 102,226 | Form 4 |
| Ruiz Briseno Andres See Remarks | 2024-03-04 17:27:48 | 85,000 0 | 85,000 | Form 4 |
| WHITE MICHAEL ANTHONY Chief Scientific Officer | 2024-05-31 16:26:47 | 64,000 0 | 64,000 | Form 4 |
| Hambleton Julie SVP, Chief Medical Officer | 2020-02-25 16:02:06 | 62,500 0 | 62,500 | Form 4 |
| Lackner Mark SVP, Head of Biology | 2021-02-26 19:10:16 | 45,000 0 | 45,000 | Form 4 |
| MACKEY CATHERINE J Director | 2024-05-31 16:30:21 | 16,200 0 | 16,200 | Form 4 |
| Kelley Susan L. Director | 2024-05-31 16:38:32 | 16,200 0 | 16,200 | Form 4 |
| ROSEN TERRY J Director | 2024-05-31 16:38:35 | 16,200 0 | 16,200 | Form 4 |
| Hampton Malcolm Garret Director | 2024-05-31 16:38:29 | 16,200 0 | 16,200 | Form 4 |
| Stein Jeffrey Director | 2024-05-31 16:38:25 | 16,200 0 | 16,200 | Form 4 |
| Morrison Scott W Director | 2024-05-31 16:38:19 | 16,200 0 | 16,200 | Form 4 |
| YARNO WENDY L Director | 2024-05-31 16:31:24 | 16,200 0 | 16,200 | Form 4 |
| SHANNON TIMOTHY M Director | 2023-06-09 16:49:22 | 16,200 0 | 16,200 | Form 4 |
| Stone Paul A. Chief Financial Officer | 2023-08-31 17:49:27 | 9,303 0 | 9,303 | Form 4 |
| Schroeder Thilo Director | 2019-05-22 21:19:52 | 0 0 | 0 | Form 3 |